Literature DB >> 4171344

When should randomisation begin?

T C Chalmers.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4171344     DOI： 10.1016/s0140-6736(68)90316-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Trials and fast changing technologies: the case for tracker studies.

Authors:  R J Lilford; D A Braunholtz; R Greenhalgh; S J Edwards
Journal:  BMJ       Date:  2000-01-01

2.  Thomas C Chalmers (1917-1995): a pioneer of randomised clinical trials and systematic reviews.

Authors:  Kay Dickersin; Frances Chalmers
Journal:  J R Soc Med       Date:  2015-06       Impact factor: 5.344

3.  Dangers of diazoxide.

Authors:  M S Knapp; R Cove-Smith; G Hall; M McIllmurray
Journal:  Br Med J       Date:  1972-10-28

4.  Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.

Authors:  Hui Tang; Nathan R Foster; Axel Grothey; Stephen M Ansell; Richard M Goldberg; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

5.  Assessing clinical trials--first steps.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

Review 6.  The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war.

Authors:  Rafael Leite Pacheco; Ana Luiza Cabrera Martimbianco; Rachel Riera
Journal:  J Clin Epidemiol       Date:  2020-12-07       Impact factor: 6.437
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.